Abstract-The intracellular action on exocytosis of botulinim A toxin and constituent chains was studied using permeabilized isolated nerve endings from the rat neural lobe. The release of the neuropeptide vasopressin was measured by radioimmunoassay. In the presence ofthe reducing agent dithiothreitol, the two-chain form of botulinum A toxin inhibited vasopressin release induced by 10 Jl M free calcium. Half maximal inhibition was obtained with 15 nM botulinum A toxin. In the absence of the heavy chain the light chain of the toxin strongly inhibited exocytosis with a half maximal effect of 2.5 nM. The inhibitory effects on secretion could be prevented by incubating the light chain with an immune serum against botulinum A toxin. The heavy chain of botulinum A toxin did not affect vasopressin release. However, it prevented the inhibitory effects of the light chain on stimulated exocytosis.It is concluded that botulinum A toxin inhibits the calcium-dependent step leading to exocytosis by interfering with a target present in the isolated and permeabilized nerve terminals. The functional domain of this neurotoxin, which is responsible for the inhibition of vasopressin release, is present in its light chain.Botulinum A toxin belongs to a family of cIosely reIated neurotoxins. The 150,000 mol. wt protein consists of a heavy chain (100,000 mol. wt) and a light chain (50,000 mol. wt) covalently linked by a disulfide bond. It inhibits neuro transmission at the peripheral cholinergic nerve endings by inhibiting neurotransmitter release. A three-step model is thought to produce the paralytic effects. It consists of (i) extracellular binding, (ii) internalization and (iii) intracellular poisoning (cf. Refs 12 and 19). The toxins' effects are restricted to the nervous tissue when given extracellularly. However, an extracellular application does not allow the differentiation of the intracellular processes involved in the final inhibition of transmitter release and the role played by the individual chains of the toxin.Recently, using cultured adrenal chromaffin cells permeabilized with streptolysin 0, it has been shown that intracellularly applied botulinum A toxin is more effective in the presence of a reducing agent. Indeed, the light chain of botulinum A toxin alone inhibited Ca 2 + -stimulated catecholamine release. 5 ,20,21 In contrast, both the heavy and the light chain must be tPresent address: